917570-06-0 Usage
Uses
Used in Pharmaceutical Industry:
2-(5-bromopyridin-2-yl)-2-methylpropanoic acid is used as a building block for the synthesis of pharmaceuticals. Its unique structure allows for the creation of new drug molecules that can target specific biological pathways, potentially leading to the development of novel therapeutics.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(5-bromopyridin-2-yl)-2-methylpropanoic acid is used as a key component in the formulation of pesticides and other crop protection products. Its chemical properties enable the development of effective agents that can protect crops from pests and diseases.
Used in Specialty Chemicals:
2-(5-bromopyridin-2-yl)-2-methylpropanoic acid is used as a reagent in the synthesis of specialty chemicals, such as dyes, pigments, and fluorescent materials. Its ability to introduce the pyridine ring into various molecular structures makes it a valuable intermediate in the production of these compounds.
Used in Organic Chemistry Research:
As a reagent in organic chemistry reactions, 2-(5-bromopyridin-2-yl)-2-methylpropanoic acid is used in processes like the Suzuki-Miyaura cross-coupling reactions. This allows for the introduction of the pyridine ring into a wide range of molecular structures, facilitating the exploration of new chemical entities and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 917570-06-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,5,7 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 917570-06:
(8*9)+(7*1)+(6*7)+(5*5)+(4*7)+(3*0)+(2*0)+(1*6)=180
180 % 10 = 0
So 917570-06-0 is a valid CAS Registry Number.
917570-06-0Relevant articles and documents
BTK INHIBITORS
-
Page/Page column 66, (2016/07/27)
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions comprising these compounds and their use in therapy. In particular, provided is the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.
BTK INHIBITORS
-
Page/Page column 90, (2016/08/03)
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, Formula I or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.
HETERO RING-FUSED IMIDAZOLE DERIVATIVE HAVING AMPK ACTIVATING EFFECT
-
, (2013/07/25)
Disclosed is a compound which is useful as an AMPK activator. A compound represented by the formula: its pharmaceutically acceptable salt, or a solvate thereof, wherein a group represented by the formula: is a group represented by the formula: R1 /s
AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS
-
Page/Page column 170, (2010/01/29)
The invention relates to compounds of formula (I) wherein R, R0, R1, m, n and X1 to X4 have the meaning as cited in the description and the claims. Said compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.